Daniel Y. Paik

Oncology | Obstetrics and Gynecology

4501 Sand Creek Road
Antioch, CA 94531

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Retraction Note: An apoptosis-enhancing drug overcomes platinum resistance in a tumour-initiating subpopulation of ovarian cancer.

Retraction Note: An apoptosis-enhancing drug overcomes platinum resistance in a tumour-initiating subpopulation of ovarian cancer.

Journal: Nature communications

Published: May 02, 2020

Real-time Doppler ultrasound to identify vessels and guide needle placement for gynecologic interstitial brachytherapy.

Real-time Doppler ultrasound to identify vessels and guide needle placement for gynecologic interstitial brachytherapy.

Journal: Brachytherapy

Published: March 21, 2018

Corrigendum: An apoptosis-enhancing drug overcomes platinum resistance in a tumour-initiating subpopulation of ovarian cancer.

Corrigendum: An apoptosis-enhancing drug overcomes platinum resistance in a tumour-initiating subpopulation of ovarian cancer.

Journal: Nature communications

Published: February 06, 2016

Corrigendum: Common variants at 19p13 are associated with susceptibility to ovarian cancer.

Corrigendum: Common variants at 19p13 are associated with susceptibility to ovarian cancer.

Journal: Nature genetics

Published: December 30, 2015

An apoptosis-enhancing drug overcomes platinum resistance in a tumour-initiating subpopulation of ovarian cancer.

An apoptosis-enhancing drug overcomes platinum resistance in a tumour-initiating subpopulation of ovarian cancer.

Journal: Nature communications

Published: June 03, 2015

Breast cancer following ovarian cancer in BRCA mutation carriers.

Breast cancer following ovarian cancer in BRCA mutation carriers.

Journal: JAMA surgery

Published: November 06, 2014

Low levels of circulating estrogen sensitize PTEN-null endometrial tumors to PARP inhibition in vivo.

Low levels of circulating estrogen sensitize PTEN-null endometrial tumors to PARP inhibition in vivo.

Journal: Molecular cancer therapeutics

Published: November 14, 2013

Progesterone receptor signaling in the microenvironment of endometrial cancer influences its response to hormonal therapy.

Progesterone receptor signaling in the microenvironment of endometrial cancer influences its response to hormonal therapy.

Journal: Cancer research

Published: June 08, 2013

Estrogen and progesterone together expand murine endometrial epithelial progenitor cells.

Estrogen and progesterone together expand murine endometrial epithelial progenitor cells.

Journal: Stem cells (Dayton, Ohio)

Published: October 12, 2012

Stem-like epithelial cells are concentrated in the distal end of the fallopian tube: a site for injury and serous cancer initiation.

Stem-like epithelial cells are concentrated in the distal end of the fallopian tube: a site for injury and serous cancer initiation.

Journal: Stem cells (Dayton, Ohio)

Published: August 23, 2012

Showing 1-10 of 10

Last Updated: 09/26/2026